Most Recent

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

Structural studies reveal how SSRI drugs bind to the human serotonin transporter.

0 Comments

image: New Epigenetic Mark Confirmed in Mammals

New Epigenetic Mark Confirmed in Mammals

By | April 1, 2016

Methylation on adenine bases is involved in the dampening of gene expression in mammalian cells, according to a study.

0 Comments

image: A Gut Feeling

A Gut Feeling

By | April 1, 2016

See profilee Hans Clevers discuss his work with stem cells and cancer in the small intestine.

0 Comments

image: A Studious Survivor

A Studious Survivor

By | April 1, 2016

Meet Lauren Bendesky, the teen who beat neuroblastoma and is now on her way to becoming a pediatric oncologist who treats and studies other kids with cancer.

0 Comments

image: A Tree  Takes Root

A Tree Takes Root

By | April 1, 2016

Four apparently unrelated individuals share a common ancestor from whom they inherited a rare mutation that predisposed them to the cancer they share.

0 Comments

image: Banking on Blood Tests

Banking on Blood Tests

By | April 1, 2016

How close are liquid biopsies to replacing current diagnostics?

1 Comment

image: Book Excerpt from <em>The Serengeti Rules</em>

Book Excerpt from The Serengeti Rules

By | April 1, 2016

In the introduction to the book, author Sean B. Carroll draws the parallels between ecological and physiological maladies.

0 Comments

image: Cancer's Vanguard

Cancer's Vanguard

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Cancerous Conduits

Cancerous Conduits

By | April 1, 2016

Metastatic cancer cells use nanotubes to manipulate blood vessels.

0 Comments

image: Contributors

Contributors

By | April 1, 2016

Meet some of the people featured in the April 2016 issue of The Scientist.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech